𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms

✍ Scribed by Cüneyt Güzey; Maria Gabriella Scordo; Edoardo Spina; Veslemøy Malm Landsem; Olav Spigset


Publisher
Springer
Year
2007
Tongue
English
Weight
174 KB
Volume
63
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Polymorphisms in dopamine receptor DRD1
✍ Vita Dolžan; Blanka Kores Plesničar; Alessandro Serretti; Laura Mandelli; Bojan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract DRD~1~ and DRD~2~ receptor gene variants have been associated with clinical aspects of schizophrenia; however only specific features were analyzed in different samples. To assess the complex interaction between genetic and clinical factors, we studied the possible cross‐interactions bet

Role of dopamine D3 receptor (DRD3) and
✍ György Szekeres; Szabolcs Kéri; Anna Juhász; Ágnes Rimanóczy; István Szendi; Cso 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 2 views

## Abstract Molecular components of the dopaminergic system may play an important role in the pathophysiology of schizophrenia. In this study, we investigated the relationship of the Ser9Gly (S/G) polymorphism of the dopamine D3 receptor (DRD3) and the variable number of tandem repeats (VNTR) polym

Association study of polymorphisms in In
✍ Arun K. Tiwari; Clement C. Zai; Herbert Y. Meltzer; Jeffrey A. Lieberman; Daniel 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Abstract ## Objective Atypical antipsychotic drugs, in particular clozapine and olanzapine, influence cellular lipogenesis and are associated with metabolic side effects including weight gain. Insulin induced gene 2 (INSIG2) mediates feedback control of lipid synthesis and polymorphisms in the

Association study of dopamine D2, D3, D4
✍ Sebastian Paus; Gert Seeger; Hans M. Brecht; Jürgen Köster; Mahha El-Faddagh; Ma 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 1 views

Sleep attacks are a common yet only recently recognized phenomenon in patients with Parkinson's disease (PD). Initially reported to occur only with particular dopamine agonists, sleep attacks have been observed with all dopaminergic drugs. [1][2][3] In the majority of affected patients, sleep attack